Severin E S, Itkes A V, Kartasheva O N, Tunitskaya V L, Turpaev K T, Kafiani C A
Adv Enzyme Regul. 1985;23:365-76. doi: 10.1016/0065-2571(85)90056-1.
The results of the present study permit the explanation of one of the mechanisms of the interconnection between the regulatory systems of cAMP and 2-5A. cAMP-dependent regulation of 2'-PDE was found to involve phosphorylation of the specific protein inhibitor. Originally, a similar way of regulation of the enzyme activity was discovered for protein phosphatase I. This enzyme has a specific protein inhibitor type 1, which is phosphorylated by cAMP-dependent protein kinase and is activated by phosphorylation (18). It is interesting that the molecular weights of 2'-PDE protein inhibitor and of the inhibitor type 1 of protein phosphatase I are essentially the same. There is also a certain similarity between the above described mechanism and phosphorylation of the regulatory subunit of cAMP-dependent protein kinase type 2. The regulatory subunit can also act as a protein inhibitor of the enzyme and change its properties as a result of phosphorylation (19). The results obtained permit as well a more detailed explanation for cAMP-dependent inhibition of cell proliferation. Evidently, cAMP elevation causes activation of cAMP-dependent phosphorylation which, in turn, leads to the induction of 2-5A synthetase and inhibition of 2'-PDE. As a result of variations in the activities of these enzymes, the level of 2-5A rises. The latter brings about the changes characteristic of the resting state. They involve activation of RNase L and the succeeding acceleration of RNA hydrolysis, inhibition of protein synthesis and cell proliferation. The resting state is characterized by a rapid turnover of macromolecules due to their intensive degradation (20). The above described scheme suggested that the rapid turnover of RNA during inhibition of cell proliferation can be partially accounted for by activation of 2-5A-dependent RNase L. Thus, it can be thought that at least one of the mechanisms of the antiproliferative effect of cAMP-dependent phosphorylation of proteins involves cAMP-dependent elevation of intracellular 2-5A. Evidently, a number of properties of the resting cells are determined by the elevated content of 2-5A. Finally, it should be noted that the interconnection between the systems of cAMP and 2-5A is a multiple process. We have earlier demonstrated (12) that 2-5A activates cAMP phosphodiesterase in NIH 3T3 cell homogenates. These data suggest that the mutual regulation of cAMP and 2-5A levels involves the negative feedback mechanism (Fig. 8).
本研究结果有助于解释环磷酸腺苷(cAMP)与2-5A调节系统之间相互联系的机制之一。发现cAMP对2'-磷酸二酯酶(2'-PDE)的依赖性调节涉及特定蛋白抑制剂的磷酸化。最初,人们发现蛋白磷酸酶I的酶活性调节方式与此类似。这种酶有一种特定的1型蛋白抑制剂,它被cAMP依赖性蛋白激酶磷酸化并因磷酸化而被激活(18)。有趣的是,2'-PDE蛋白抑制剂和蛋白磷酸酶I的1型抑制剂的分子量基本相同。上述机制与2型cAMP依赖性蛋白激酶调节亚基的磷酸化之间也存在一定相似性。调节亚基也可作为该酶的蛋白抑制剂,并因磷酸化而改变其特性(19)。所获得的结果也有助于更详细地解释cAMP对细胞增殖的依赖性抑制。显然,cAMP水平升高会导致cAMP依赖性磷酸化的激活,进而导致2-5A合成酶的诱导和2'-PDE的抑制。由于这些酶活性的变化,2-5A水平升高。后者引起静止状态特有的变化。这些变化包括核糖核酸酶L的激活以及随后RNA水解的加速、蛋白质合成和细胞增殖的抑制。静止状态的特征是由于大分子的大量降解而导致的快速周转(20)。上述方案表明,细胞增殖受抑制期间RNA的快速周转可部分归因于2-5A依赖性核糖核酸酶L的激活。因此,可以认为蛋白的cAMP依赖性磷酸化的抗增殖作用的至少一种机制涉及细胞内2-5A的cAMP依赖性升高。显然,静止细胞的许多特性由2-5A含量的升高所决定。最后,应该指出,cAMP和2-5A系统之间的相互联系是一个多步骤过程。我们之前已经证明(12),2-5A可激活NIH 3T3细胞匀浆中的cAMP磷酸二酯酶。这些数据表明,cAMP和2-5A水平的相互调节涉及负反馈机制(图8)。